NKTR vs. BRK-B
Compare and contrast key facts about Nektar Therapeutics (NKTR) and Berkshire Hathaway Inc. (BRK-B).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: NKTR or BRK-B.
Correlation
The correlation between NKTR and BRK-B is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
NKTR vs. BRK-B - Performance Comparison
Key characteristics
NKTR:
0.39
BRK-B:
1.25
NKTR:
1.30
BRK-B:
1.85
NKTR:
1.14
BRK-B:
1.23
NKTR:
0.35
BRK-B:
2.23
NKTR:
1.06
BRK-B:
5.25
NKTR:
32.46%
BRK-B:
3.56%
NKTR:
88.12%
BRK-B:
14.93%
NKTR:
-99.61%
BRK-B:
-53.86%
NKTR:
-99.12%
BRK-B:
-0.41%
Fundamentals
NKTR:
$184.46M
BRK-B:
$1.04T
NKTR:
-$0.84
BRK-B:
$49.44
NKTR:
3.22
BRK-B:
10.06
NKTR:
$69.25M
BRK-B:
$276.52B
NKTR:
$46.54M
BRK-B:
$48.42B
NKTR:
-$104.18M
BRK-B:
$98.94B
Returns By Period
In the year-to-date period, NKTR achieves a 2.89% return, which is significantly lower than BRK-B's 6.29% return. Over the past 10 years, NKTR has underperformed BRK-B with an annualized return of -23.35%, while BRK-B has yielded a comparatively higher 12.61% annualized return.
NKTR
2.89%
5.85%
-20.59%
38.68%
-47.40%
-23.35%
BRK-B
6.29%
2.82%
7.30%
17.73%
16.06%
12.61%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
NKTR vs. BRK-B — Risk-Adjusted Performance Rank
NKTR
BRK-B
NKTR vs. BRK-B - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Nektar Therapeutics (NKTR) and Berkshire Hathaway Inc. (BRK-B). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
NKTR vs. BRK-B - Dividend Comparison
Neither NKTR nor BRK-B has paid dividends to shareholders.
Drawdowns
NKTR vs. BRK-B - Drawdown Comparison
The maximum NKTR drawdown since its inception was -99.61%, which is greater than BRK-B's maximum drawdown of -53.86%. Use the drawdown chart below to compare losses from any high point for NKTR and BRK-B. For additional features, visit the drawdowns tool.
Volatility
NKTR vs. BRK-B - Volatility Comparison
Nektar Therapeutics (NKTR) has a higher volatility of 30.35% compared to Berkshire Hathaway Inc. (BRK-B) at 4.62%. This indicates that NKTR's price experiences larger fluctuations and is considered to be riskier than BRK-B based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
NKTR vs. BRK-B - Financials Comparison
This section allows you to compare key financial metrics between Nektar Therapeutics and Berkshire Hathaway Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities